Reaction of dirhodium and diruthenium paddlewheel tetraacetate complexes with nucleophilic protein sites: A computational study

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Inorganica Chimica Acta

• Publication date

  2021-11-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.ica.2021.120684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Binding of histidine and human serum albumin to dirhodium(II) tetraacetate.

  2021cited by this paper
• Unusual Structural Features in the Adduct of Dirhodium Tetraacetate with Lysozyme

  2021cited by this paper
• Reactivity of antitumor coinage metal-based N-heterocyclic carbene complexes with cysteine and selenocysteine protein sites.

  2021cited by this paper
• The interaction of rhodium compounds with proteins: A structural overview

  2021cited by this paper
• Two mixed valence diruthenium(II,III) isomeric complexes show different anticancer properties.

  2021cited by this paper
• Molecular dynamics simulation of the Pb(II) coordination in biological media via cationic dummy atom models

  2021cited by this paper
• Insight into the Substitution Mechanism of Antitumor Au(I) N-Heterocyclic Carbene Complexes by Cysteine and Selenocysteine.

  2020cited by this paper
• Protein interactions of dirhodium tetraacetate: a structural study.

  2020cited by this paper
• Reactivity of arsenoplatin complex versus water and thiocyanate: a DFT benchmark study

  2020cited by this paper
• Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis.

  2020cited by this paper
• A mixed-valence diruthenium(II,III) complex endowed with high stability: from experimental evidence to theoretical interpretation.

  2020cited by this paper
• Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study

  2020cited by this paper
• Cisplatin: The first metal based anticancer drug.

  2019cited by this paper
• Reactions of Rh2(CH3COO)4 with thiols and thiolates: a structural study.

  2019cited by this paper
• Review on Pharmacology of Cisplatin: Clinical Use, Toxicity and Mechanism of Resistance of Cisplatin

  2019cited by this paper
• Reaction of dirhodium(II) tetraacetate with S-methyl-L-cysteine

  2019cited by this paper
• New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment

  2019cited by this paper
• Advances in Toxicological Research of the Anticancer Drug Cisplatin.

  2019cited by this paper
• Comprehensive Thermochemical Benchmark Set of Realistic Closed-Shell Metal Organic Reactions.

  2018cited by this paper
• Protein Scaffold Activates Catalytic CO2 Hydrogenation by a Rhodium Bis(diphosphine) Complex

  2018cited by this paper
• Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic.

  2018cited by this paper
• Methionine Binding to Dirhodium(II) Tetraacetate.

  2018cited by this paper
• Insights on the activity of platinum-based anticancer complexes through computational methods

  2018cited by this paper
• Metallothionein: An Aggressive Scavenger—The Metabolism of Rhodium(II) Tetraacetate (Rh2(CH3CO2)4)

  2018cited by this paper
• Reactions of Antitumor Active Dirhodium(II) Tetraacetate Rh2(CH3COO)4 with Cysteine and Its Derivatives

  2017cited by this paper
• Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells.

  2017cited by this paper
• A Comprehensive Comparison of the IEFPCM and SS(V)PE Continuum Solvation Methods with the COSMO Approach.

  2015cited by this paper
• Comparative Assessment of DFT Performances in Ru- and Rh-Promoted σ-Bond Activations.

  2015cited by this paper
• Unusual structural features in the lysozyme derivative of the tetrakis(acetato)chloridodiruthenium(II,III) complex.

  2014cited by this paper
• Artificial metalloenzymes derived from bovine β-lactoglobulin for the asymmetric transfer hydrogenation of an aryl ketone--synthesis, characterization and catalytic activity.

  2014cited by this paper
• Sequence-specific inhibition of a designed metallopeptide catalyst.

  2012cited by this paper
• Catalytic protein modification with dirhodium metallopeptides: specificity in designed and natural systems.

  2012cited by this paper
• Thermodynamics of axial substitution and kinetics of reactions with amino acids for the paddlewheel complex tetrakis(acetato)chloridodiruthenium(II,III).

  2012cited by this paper
• A general synthesis of dirhodium metallopeptides as MDM2 ligands.

  2011cited by this paper
• Systematic optimization of long-range corrected hybrid density functionals.

  2008cited by this paper
• Dirhodium complexes of amino acid derivatives: separation and characterization by circular dichroism spectroscopy

  2008cited by this paper
• Diruthenium(II, III) complexes of ibuprofen, aspirin, naproxen and indomethacin non-steroidal anti-inflammatory drugs: Synthesis, characterization and their effects on tumor-cell proliferation

  2008cited by this paper
• Single-ion solvation free energies and the normal hydrogen electrode potential in methanol, acetonitrile, and dimethyl sulfoxide.

  2007cited by this paper
• Effects of axial coordination on the Ru-Ru single bond in diruthenium paddlewheel complexes.

  2006cited by this paper
• Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: Design and assessment of accuracy.

  2005cited by this paper
• Hydrogen bonding in diruthenium(II,III) tetraacetate complexes with biologically relevant axial ligands

  2005cited by this paper
• Effect of equatorial ligands of dirhodium(II,II) complexes on the efficiency and mechanism of transcription inhibition in vitro.

  2004cited by this paper
• Dirhodium tetracarboxylate scaffolds as reversible fluorescence-based nitric oxide sensors.

  2004cited by this paper
• Diruthenium tetraacetate monocation, [RuII/III2(O2CMe)4]+, building blocks for 3-D molecule-based magnets.

  2004cited by this paper
• Recent developments in the synthesis and properties of diruthenium tetracarboxylates

  2004cited by this paper
• Inhibition of transcription in vitro by anticancer active dirhodium(II) complexes.

  2003cited by this paper
• Correlation between sequence hydrophobicity and surface‐exposure pattern of database proteins

  2003cited by this paper
• Effects of human serun albumin in some biological properties of rhodium(II) complexes

  2000cited by this paper
• The IEF version of the PCM solvation method: an overview of a new method addressed to study molecular solutes at the QM ab initio level

  1999cited by this paper
• Preparation and properties of a series of (μ-oxo)di(μ-acetato) diruthenium(III) complexes, [Ru2(μ-O)(μ-CH3COO)2(pyridine)4(L)2]2+ and [Ru2(μ-O)(μ-CH3COO)2(AA)2(L)2]2+, where AA is 2,2′-bipyridine or 1,10-phenanthroline, and L is a monodentate ligand

  1998cited by this paper
• Interaction of tetra-μ-acetatodirhodium(II) with human serum albumin

  1995cited by this paper
• Biological Activity and Crystallographic Study of a Rhodium Propionate-Metronidazole Adduct

  1994cited by this paper
• Energy-adjustedab initio pseudopotentials for the second and third row transition elements

  1990cited by this paper
• Free energy of TIP4P water and the free energies of hydration of CH4 and Cl- from statistical perturbation theory

  1989cited by this paper
• Antitumor effects of rhodium (II) citrate in mice bearing Ehrlich tumors.

  1989cited by this paper
• Binuclear transition-metal complexes as new reagents for selective cross-linking of proteins. Coordination of cytochrome c to dirhodium(II). mu. -tetraacetate

  1988cited by this paper
• Dirhodium(II,II) tetra-acetate complexes with axially co-ordinated triphenylstibine, triphenylarsine, and dibenzyl sulphide ligands. The syntheses, properties, and X-ray crystal structures of [Rh2(O2CMe)4(SbPh3)2], [Rh2(O2CMe)4(AsPh3)2], and [Rh2(O2CMe)4{S(CH2Ph)2}2]

  1985cited by this paper
• Crystal structure and polarized electronic spectra for diruthenium tetraacetate chloride

  1980cited by this paper
• The Crystal Structure of Tetra-μ-acetato-diruthenium Chloride

  1980cited by this paper
• Structural Studies of Some Multiply Bonded Diruthenium Tetracarboxylate Compounds

  1979cited by this paper
• Mechanism of action of tetra-mu-carboxylatodirhodium(II) in L1210 tumor suspension culture.

  1979cited by this paper
• The interaction of rhodium(II) carboxylates with enzymes.

  1976cited by this paper
• Studies of Rhodium(II) Carboxylates as Potential Antitumor Agents 1

  1974cited by this paper

• From simple to complex: multiscale modeling of metal-mediated protein interactions to uncover mechanistic insights into the action of inorganic drugs

  2026cites this paper
• Dirhodium Tetraacetate Binding to Lysozyme at Body Temperature

  2025cites this paper
• Coordination of a Dirhodium(II) Center to Methionine and Cysteine Side Chains: Evidence from X-Ray Structure of the Adduct Formed by Dirhodium Tetraacetate with a C-Phycocyanin

  2025influential citation
• Mechanism of Action of Antitumor Au(I) N-Heterocyclic Carbene Complexes: A Computational Insight on the Targeting of TrxR Selenocysteine

  2024cites this paper
• Noble Metal Nanoparticles with Nanogel Coatings: Coinage Metal Thiolate-Stabilized Glutathione Hydrogel Shells

  2024cites this paper
• The binding of auranofin at DNA/RNA nucleobases: A DFT assessment

  2024cites this paper
• Unveiling the mechanism of activation of the Te(IV) prodrug AS101. New chemical insights towards a better understanding of its medicinal properties.

  2024cites this paper
• Diruthenium Paddlewheel Complexes Attacking Proteins: Axial versus Equatorial Coordination

  2024influential citation
• The binding of diruthenium (II,III) and dirhodium (II,II) paddlewheel complexes at DNA/RNA nucleobases: Computational evidences of an appreciable selectivity toward the AU base pairs.

  2024cites this paper
• Overcoming Resistance of Caco-2 Cells to 5-Fluorouracil through Diruthenium Complex Encapsulation in PMMA Nanoparticles

  2024cites this paper
• Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety

  2023cites this paper
• Steric hindrance and charge influence on the cytotoxic activity and protein binding properties of diruthenium complexes.

  2023cites this paper
• Effect of Equatorial Ligand Substitution on the Reactivity with Proteins of Paddlewheel Diruthenium Complexes: Structural Studies

  2023cites this paper
• Auranofin Targeting the NDM-1 Beta-Lactamase: Computational Insights into the Electronic Configuration and Quasi-Tetrahedral Coordination of Gold Ions

  2023cites this paper
• Selenocysteine of thioredoxin reductase as the primary target for the antitumor metallodrugs: A computational point of view

  2022cites this paper
• Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study

  2022cites this paper
• Kinetics of Reactions of Dirhodium and Diruthenium Paddlewheel Tetraacetate Complexes with Nucleophilic Protein Sites: Computational Insights.

  2022cites this paper
• Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey

  2021cites this paper